-
Are These Science Fiction Concepts In Our Future?
Let’s explore some of these possibilities in turn to answer this question.
-
Covid-19 Antibodies Cut Viral Load, Medical Visits
Interim results from a clinical trial show a synthetic antibody drug reduces viral burden and medical visits among non-hospitalized Covid-19 patients.
-
200M Covid-19 Vaccine Doses Donated to Int’l Effort
Sanofi and GlaxoSmithKline are offering 200 million doses of their Covid-19 vaccine for a project devoted to making vaccines equitably available worldwide.
-
Helping an Employee Back Into the Office
What does it take to get an employee back to work in difficult times but also after an employee’s individual difficult time?
-
Novartis Gains Synthetic Protein Therapies for Covid-19
Global drug maker Novartis is gaining access to two Covid-19 therapy candidates made from a library of synthetic protein components.
-
Better Precision Medicine Outcomes Shown for Leukemia
Clinical trial results show a strategy that first tests for genomic mutations to guide treatments results in better outcomes for patients with acute myeloid leukemia.
-
Lilly, NIH Halt Covid-19 Antibody Therapy Trial
Drug maker Eli Lilly and National Institutes of Health are stopping a clinical trial testing a synthetic antibody to treat hospitalized Covid-19 patients.
-
Think About Your Real Business Needs
One of the most important things that you have to consider is whether a decision you make is based on what you want or what your business needs.
-
Bayer Gains Gene Therapy Biotech in $4B Deal
Global drug maker Bayer AG is acquiring the company Asklepios BioPharmaceutical, developer of gene therapies to treat inherited disorders.
-
Precision Drug Trial Shows Solid Tumor Shrinkage
Partial results from a clinical trial show a drug to stop specific cancer-causing proteins shrinks advanced tumors in some patients across several tumor types.